Pituitary Macroadenoma Development in Transgender Women Receiving Gender-Affirming Hormone Therapy: A Call for Baseline Prolactin Screening Prior to Initiation of Therapy
Pituitary Macroadenoma Development in Transgender Women Receiving Gender-Affirming Hormone Therapy: A Call for Baseline Prolactin Screening Prior to Initiation of Therapy. // AACE Endocrinology and Diabetes. – URL: https://www.sciencedirect.com/science/article/pii/S3050915726002638?dgcid=rss_sd_all
Pituitary Macroadenoma Development in Transgender Women Receiving Gender-Affirming Hormone Therapy: A Call for Baseline Prolactin Screening Prior to Initiation of Therapy. AACE Endocrinology and Diabetes. https://www.sciencedirect.com/science/article/pii/S3050915726002638?dgcid=rss_sd_all
“Pituitary Macroadenoma Development in Transgender Women Receiving Gender-Affirming Hormone Therapy: A Call for Baseline Prolactin Screening Prior to Initiation of Therapy.” AACE Endocrinology and Diabetes.
@article{article32621,
title = {Pituitary Macroadenoma Development in Transgender Women Receiving Gender-Affirming Hormone Therapy: A Call for Baseline Prolactin Screening Prior to Initiation of Therapy},
journal = {AACE Endocrinology and Diabetes},
url = {https://www.sciencedirect.com/science/article/pii/S3050915726002638?dgcid=rss_sd_all}
}